Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production

被引:0
|
作者
Qing-Meng Zhang
Wu-Qi Song
Yu-Jun Li
Jun Qian
Ai-Xia Zhai
Jing Wu
Ai-Mei Li
Jun-Ming He
Jin-Yun Zhao
Xin Yu
Lan-Lan Wei
Feng-Min Zhang
机构
[1] Harbin Medical University,The Key Laboratory of Immunity and Infection, Pathogenic Biology, Department of Microbiology
[2] Harbin Medical University,Bio
来源
关键词
Mitochondrial antiviral signaling protein; Coxsackievirus B3; Interferon; Antiviral response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 29 条
  • [1] Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production
    Zhang, Qing-Meng
    Song, Wu-Qi
    Li, Yu-Jun
    Qian, Jun
    Zhai, Ai-Xia
    Wu, Jing
    Li, Ai-Mei
    He, Jun-Ming
    Zhao, Jin-Yun
    Yu, Xin
    Wei, Lan-Lan
    Zhang, Feng-Min
    VIROLOGY JOURNAL, 2012, 9
  • [2] DEVELOPMENT OF ANTIVIRAL THERAPEUTICS COMBATING COXSACKIEVIRUS TYPE B3 INFECTION
    Volobueva, A. S.
    Zarubaev, V. V.
    Lantseva, K. S.
    INFEKTSIYA I IMMUNITET, 2021, 11 (01): : 57 - 67
  • [3] Interleukin-1 type I receptor signaling triggers the inflammatory response in Coxsackievirus B3 infection
    Rehren, Fabienne
    Dittrich-Breiholz, Oliver
    Kracht, Michael
    Heim, Albert
    CYTOKINE, 2009, 48 (1-2) : 64 - 64
  • [4] Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis
    Li, Min
    Yan, Kepeng
    Wei, Lin
    Yang, Jie
    Lu, Chenyu
    Xiong, Fei
    Zheng, Chunfu
    Xu, Wei
    ANTIVIRAL RESEARCH, 2015, 123 : 50 - 61
  • [5] Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling - Implications for mortality and early viral replication
    Wessely, R
    Klingel, K
    Knowlton, KU
    Kandolf, R
    CIRCULATION, 2001, 103 (05) : 756 - 761
  • [6] ALTERATIONS IN G-PROTEIN-REGULATED TRANSMEMBRANE SIGNALING INDUCED IN MURINE MYOCARDIUM BY COXSACKIEVIRUS B3 INFECTION
    NOVOTNY, J
    KVAPIL, P
    JELINEK, F
    RANSNAS, LA
    CARDIOVASCULAR RESEARCH, 1995, 30 (04) : 602 - 610
  • [7] c-FLIP-Short Reduces Type I Interferon Production and Increases Viremia with Coxsackievirus B3
    Buskiewicz, Iwona A.
    Koenig, Andreas
    Roberts, Brian
    Russell, Jennifer
    Shi, Cuixia
    Lee, Sun-Hwa
    Jung, Jae U.
    Huber, Sally A.
    Budd, Ralph C.
    PLOS ONE, 2014, 9 (05):
  • [8] ISG15 blocks cardiac glycolysis and ensures sufficient mitochondrial energy production during Coxsackievirus B3 infection
    Bredow, Clara
    Thery, Fabien
    Wirth, Eva Katrin
    Ochs, Sarah
    Kespohl, Meike
    Kleinau, Gunnar
    Kelm, Nicolas
    Gimber, Niclas
    Schmoranzer, Jan
    Voss, Martin
    Klingel, Karin
    Spranger, Joachim
    Renko, Kostja
    Ralser, Markus
    Muelleder, Michael
    Heuser, Arnd
    Knobeloch, Klaus-Peter
    Scheerer, Patrick
    Kirwan, Jennifer
    Bruening, Ulrike
    Berndt, Nikolaus
    Impens, Francis
    Beling, Antje
    CARDIOVASCULAR RESEARCH, 2024, 120 (06) : 644 - 657
  • [9] OVER-EXPRESSION OF TNNI3K, A CARDIAC SPECIFIC KINASE, EXACERBATES INFLAMMATION IN COXSACKIEVIRUS B3 (CVB3) MEDIATED VIRAL MYOCARDITIS
    Parikh, S.
    Force, T.
    Bucek, A.
    Fairweather, D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (04) : 703 - 703
  • [10] TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production
    Liu, Hui
    Li, Min
    Song, Yahui
    Xu, Wei
    FRONTIERS IN IMMUNOLOGY, 2018, 9